ANI PHARMACEUTICALS INC (ANIP) insider trading

By person

16 insiders · 3 transactions

29.0×

Nikhil Lalwani holds 29.0 times base salary in stock. $24.32M of shares against $837.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Nikhil Lalwani last reported holding, valued at $72.87, the price Common Stock was last bought or sold at on the open market here, on 29 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Nikhil Lalwani

President & CEO

—

$388.21K (1) scheduled

−$388.21K

333,689

1.48%

$24.32M

−10.7%

Stephen P. Carey

SVP & CFO

—

$207.68K (1) scheduled

−$207.68K

166,143

0.7387%

$12.11M

+2.6%

Meredith Cook

Sr. VP, General Counsel & Sec.

—

$36.80K (1) scheduled

−$36.80K

73,424

0.3265%

$5.35M

+30.0%

Muthusamy Shanmugam

Head of R&D, COO-Novitium Ops

—

532,976

2.37%

$38.84M

−24.0%

Chad Gassert

SVP - Corp. Dev. & Strategy

—

233,406

1.04%

$17.01M

−3.9%

Christopher Mutz

Head of Rare Disease

—

91,309

0.4060%

$6.65M

+9.6%

Ori Gutwerg

SVP, Generics

—

75,534

0.3358%

$5.50M

−2.2%

Krista Davis

SVP, Chief HR Officer

—

51,946

0.2310%

$3.79M

+3.8%

Thomas Haughey

Director

—

38,878

0.1729%

$2.83M

−24.5%

Patrick D Walsh

Director

—

38,432

0.1709%

$2.80M

−48.6%

Thomas Andrew Rowland

SVP, Head - Established Brands

—

38,271

0.1702%

$2.79M

+9.6%

Renee P Tannenbaum

Director

—

29,514

0.1312%

$2.15M

+30.5%

Antonio R Pera

Director

—

27,017

0.1201%

$1.97M

−13.0%

Jeanne Thoma

Director

—

26,762

0.1190%

$1.95M

−34.1%

Matthew J Leonard

Director

—

11,221

0.0499%

$817.67K

−6.4%

Henry O Gosebruch

Director

—

6,662

0.0296%

$485.46K

—

ANI PHARMACEUTICALS INC

What the insiders did Scheduled selling only

By person